Advanced Cholangiocarcinoma Treatment Infigratinib Granted Accelerated Approval by FDA

According to a recent article at Pharmacy Times, Infigratinib has been granted accelerated approval for the treatment of those with metastatic cholangiocarcinoma. The treatment is for adults whose cholangiocarcinoma is…

Continue Reading Advanced Cholangiocarcinoma Treatment Infigratinib Granted Accelerated Approval by FDA
Phase 3 Global Trial for Cholangiocarcinoma Testing a Single Agent is Well Underway
source: pixabay.com

Phase 3 Global Trial for Cholangiocarcinoma Testing a Single Agent is Well Underway

Updates from the Phase 3 clinical trial called FIGHT-302 were just released at the 2021 European Society for Medical Oncology World Congress on Gastrointestinal Cancer. The trial is comparing two…

Continue Reading Phase 3 Global Trial for Cholangiocarcinoma Testing a Single Agent is Well Underway
Survey Finds Cholangiocarcinoma Oncologists Could Improve Patient Care by Collaborating with Pharmacists
source: pixabay.com

Survey Finds Cholangiocarcinoma Oncologists Could Improve Patient Care by Collaborating with Pharmacists

A survey of oncologists has found that more education is clearly needed regarding cholangiocarcinoma. Specifically, more education would be beneficial regarding testing and targeting the mutations which cause the condition…

Continue Reading Survey Finds Cholangiocarcinoma Oncologists Could Improve Patient Care by Collaborating with Pharmacists